Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children

Allergy, Asthma and Clinical Immunology

Volumn 3, Issue 4, 2007, Pages 114-122

  Kidon, Mona Iancovici ^a,c   Kang, Liew Woei ^a   Chin, Chiang Wen ^a   Hoon, Lim Siok ^a   Hugo, Van Bever ^b  

^a KK Children's Hospital   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c NONE   (Singapore)

Author keywords

Acetaminophen; Acetylsalicylic acid (ASA); Children; Hypersensitivity; Ibuprofen; NSAID; Preschool

Indexed keywords

ACETYLSALICYLIC ACID; GAMMA INTERFERON; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; TRANSCRIPTION FACTOR T BET;

AGE DISTRIBUTION; ANTIGEN PRESENTATION; ASTHMA; CHILD; CLINICAL FEATURE; CROSS REACTION; CYTOKINE PRODUCTION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; FEVER; GOLD STANDARD; HUMAN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROVOCATION TEST; REVIEW; RISK FACTOR; SEX DIFFERENCE; VIRUS INFECTION;

EID: 67650094702     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2007.00008     Document Type: Review

References (56)

1. Aspirin and Reye syndrome. Committee on Infectious Diseases. Pediatrics 1982;69:810-2.
2. Drug and Device Approvals - March 1995. 1995. U.S. Food and Drug administration, Center for Drug Evaluation and Research.
3. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002;99:13926-31.
4. Stevenson DD, Simon RA, Zuraw BL. Sensitivity to Aspirin and Nonsteroidal Antiinflammatory Drugs. In: Elliott Middleton J, Charles E Reed, Elliot F. Ellis, N. Franklin Adkinson J, John W. Yunginger, William W Busse, editors. Adkinson: Middleton's Allergy, Principles and Practice. 6 ed. Mosby Inc.; 2003. p. 1695.
5. Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980;35:149-54.
6. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996;42:319-24.
7. Kidon MI, See Y. Adverse drug reactions in Singaporean children. Singapore Med J 2004;45:574-7.
8. Titchen T, Cranswick N, Beggs S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol 2005; 59:718-23.
9. Vedanthan PK, Menon MM, Bell TD, Bergin D. Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma. J Allergy Clin Immunol 1977;60:8-13.
10. Schuhl JF, Pereyra JG. Oral acetylsalicylic acid (aspirin) challenge in asthmatic children. Clin Allergy 1979;9:83-8.
11. Rachelefsky GS, Coulson A, Siegel SC, Stiehm ER. Aspirin intolerance in chronic childhood asthma: Detected by oral challenge. Pediatrics 1975;56:443-8.
12. Falliers CJ. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol 1973;52:141-7.
13. Capriles-Behrens E, Caplin J, Sanchez-Borges M. NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 2000;10:277-9.
14. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000;84:101-6.
15. Kidon MI, Kang LW, Chin CW, et al. Early Presentation With Angioedema and Urticaria in Cross-reactive Hypersensitivity to Nonsteroidal Antiinflammatory Drugs Among Young, Asian, Atopic Children. Pediatrics 2005.
16. Speer F, Denison TR, Baptist JE. Aspirin allergy. Ann Allergy 1981; 46:123-6.
17. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999;104:e39.
18. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109:E20.
19. Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996;154:1608-14.
20. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
21. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:1599-600.
22. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000;23:290-6.
23. Yoshida S, Sakamoto H, Ishizaki Y, et al. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. Clin Exp Allergy 2000;30:64-70.
24. Dahlen SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:9-14.
25. Van Sambeek R, Stevenson DD, Baldasaro M, et al. 5′ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000;106: 72-6.
26. Choi JH, Kim SH, Bae JS, et al. Lack of an association between a newly identified promoter polymorphism (-1702G. > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population. Tohoku J Exp Med 2006;208:49-56.
27. Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 1997;52:470-3.
28. Akahoshi M, Obara K, Hirota T, et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet 2005;117:16-26.
29. Dekker JW, Nizankowska E, Schmitz-Schumann M, et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997;27:574-7.
30. Choi JH, Lee KW, Oh HB, et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol 2004;113:562-4.
31. Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 1988;18:15-20.
32. Tan Y, Collins-Williams C. Aspirin-induced asthma in children. Ann Allergy 1982;48:1-5.
33. Kauppinen K, Juntunen K, Lanki H. Urticaria in children. Retrospective evaluation and follow-up. Allergy 1984;39:469-72.
34. Legrain V, Taieb A, Sage T, Maleville J. Urticaria in infants: a study of forty patients. Pediatr Dermatol 1990;7:101-7.
35. Moore-Robinson M, Warin RP. Effect of salicylates in urticaria. Br Med J 1967;4:262-4.
36. Wright AL, Minford A. Urticaria and hidden salicylates. Pediatr Dermatol 1999;16:463-4.
37. Botey J, Ibero M, Malet A, et al. Aspirin-induced recurrent urticaria and recurrent angioedema in non-atopic children. Ann Allergy 1984;53:265-7.
38. Diaz JM, Perez MA, Gracia Bara MT, et al. Allergic reactions due to ibuprofen in children. Pediatr Dermatol 2001;18:66-7.
39. de Almeida MA, Gaspar AP, Carvalho FS, et al. Adverse reactions to acetaminophen, ASA, and NSAIDs in children: what alternatives. Allergy Asthma Proc 1997;18:313-8.
40. Botey J, Navarro C, Aulesa C, et al. Acetyl salicylic acid induced-urticaria and/or angioedema in atopic children. Allergol Immunopathol (Madr) 1988;16:43-7.
41. Kidon MI, Abramovitch I, Steinberg S, et al. Cross reactive hypersensitivity to COX inhibitors in a child with mild Allergic Rhinitis, a case report. IMAJ 2005;Accepted for publication.
42. Goraya JS, Virdi VS. To the editor: Exacerbation of asthma by ibuprofen in a very young child. Pediatr Pulmonol 2001;32:262.
43. Sehgal VN. Paracetamol-induced bilateral symmetric, multiple fixed drug eruption (MFDE) in a child. Pediatr Dermatol 1999;16: 165-6.
44. Halevi A, Ben Amitai D, Garty BZ. Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000; 34:32-4.
45. Dogra S, Handa S. Bullous necrotizing fixed drug eruption in an infant. Pediatr Dermatol 2004;21:281-2.
46. Kanwar AJ, Bharija SC, Belhaj MS. Fixed drug eruptions in children: a series of 23 cases with provocative tests. Dermatologica 1986;172:315-8.
47. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63.
48. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003;111:1095-8.
49. Boussetta K, Ponvert C, Karila C, et al. Hypersensitivity reactions to paracetamol in children: a study of 25 cases. Allergy 2005;60: 1174-7.
50. Pastorello EA, Zara C, Riario-Sforza GG, et al. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998;53:880-4.
51. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003;111:1116-21.
52. Sanchez BM, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87: 201-4.
53. Debley JS, Carter ER, Gibson RL, et al. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J Pediatr 2005;147: 233-8.
54. Gray PA, Warner TD, Vojnovic I, et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Br J Pharmacol 2002;137:1031-8.
55. Dahlen B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med 2001;344:142.
56. Garcia-Rodriguez RM, Hinojosa M, Camacho-Garrido E, et al. Celecoxib, safe in NSAID intolerance. Allergy 2002;57:1085-6.